Kriti Nutrients Ltd Valuation Shifts: From Attractive to Fair Amid Market Volatility

Valuation Metrics and Recent Changes

As of 26 May 2026, Kriti Nutrients’ price-to-earnings (P/E) ratio stands at 13.88, a figure that positions the stock in the fair valuation category, a downgrade from its previous attractive status. The price-to-book value (P/BV) ratio is currently 2.06, indicating moderate premium pricing relative to its net asset value. Other valuation multiples include an enterprise value to EBIT (EV/EBIT) of 11.27 and an EV to EBITDA of 9.77, both reflecting a valuation that is neither expensive nor deeply discounted.

These multiples contrast with some of Kriti Nutrients’ peers in the edible oil industry. For instance, BCL Industries is rated very attractive with a P/E of 8.62 and EV/EBITDA of 6.46, while KSE boasts an even lower P/E of 7.52 and EV/EBITDA of 4.28, signalling more compelling valuation opportunities within the sector. Conversely, Shri Venkatesh is considered risky with a P/E of 37.17 and EV/EBITDA of 26.75, highlighting the wide valuation spectrum in the industry.

Operational Performance and Returns

Kriti Nutrients’ operational efficiency remains solid, with a return on capital employed (ROCE) of 18.68% and return on equity (ROE) of 14.80%. These figures underscore the company’s ability to generate healthy returns on invested capital and shareholder equity, supporting its valuation despite the recent downgrade.

The stock price has shown resilience, closing at ₹93.95 on 26 May 2026, up 5.00% from the previous close of ₹89.48. The 52-week trading range spans from ₹52.25 to ₹125.00, indicating significant volatility but also substantial upside potential from recent lows.

Relative Performance Versus Sensex

When compared to the broader market benchmark, the Sensex, Kriti Nutrients has outperformed markedly over several time horizons. Year-to-date (YTD), the stock has delivered a 36.77% return, while the Sensex has declined by 10.25%. Over three and five years, Kriti Nutrients has generated returns of 92.52% and 115.48%, respectively, far exceeding the Sensex’s 23.62% and 51.05% gains. Even over a decade, the stock’s 403.75% appreciation dwarfs the Sensex’s 195.54% rise.

However, the stock has experienced a 15.04% decline over the past year, underperforming the Sensex’s 6.40% fall, which may have contributed to the more cautious valuation stance.

Valuation Grade Downgrade and Market Implications

The downgrade from an attractive to a fair valuation grade, as reflected in the MarketsMOJO Mojo Score of 47.0 and a current Mojo Grade of Sell (previously Hold as of 25 May 2026), signals a more cautious outlook from market analysts. This shift is likely influenced by the stock’s stretched valuation relative to some peers and the recent price volatility.

While Kriti Nutrients’ P/E ratio of 13.88 is moderate, it is notably higher than several very attractive peers such as BCL Industries and KSE, which trade at P/E multiples below 9. The EV/EBITDA multiple of 9.77 also suggests the stock is priced at a premium compared to the sector’s most attractively valued companies.

Investors should consider that the company’s PEG ratio remains at 0.00, indicating either a lack of meaningful earnings growth expectations or data unavailability, which may further temper enthusiasm. The dividend yield of 3.51% provides some income cushion, but it may not fully offset valuation concerns.

Peer Comparison Highlights

Within the edible oil sector, valuation disparities are pronounced. Kriti Nutrients’ fair rating contrasts with several peers rated very attractive, including Ajanta Soya (P/E 13.43, EV/EBITDA 7.96) and Vijay Solvex (P/E 12.54, EV/EBITDA 7.06). These companies offer lower multiples and potentially better risk-reward profiles.

On the other hand, some companies like Shri Venkatesh, with a P/E of 37.17 and EV/EBITDA of 26.75, are considered risky due to stretched valuations. This context places Kriti Nutrients in a middle ground, where valuation is fair but not compelling enough to warrant a buy recommendation at present.

Investment Considerations and Outlook

Investors evaluating Kriti Nutrients should weigh the company’s solid operational returns and strong historical price appreciation against the recent valuation moderation and peer comparisons. The stock’s micro-cap status introduces additional volatility and liquidity considerations, which may not suit all portfolios.

Given the current fair valuation grade and a Mojo Grade of Sell, cautious investors might prefer to monitor the stock for further price consolidation or look towards more attractively valued peers within the edible oil sector. The company’s dividend yield and return metrics provide some support, but the lack of growth visibility reflected in the PEG ratio warrants prudence.

In summary, Kriti Nutrients remains a fundamentally sound company with commendable returns over the medium and long term. However, the shift in valuation parameters suggests that the market is recalibrating expectations, and investors should carefully assess relative value and risk before committing fresh capital.

Summary of Key Financial Metrics

• P/E Ratio: 13.88 (Fair valuation)
• Price to Book Value: 2.06
• EV/EBIT: 11.27
• EV/EBITDA: 9.77
• PEG Ratio: 0.00
• Dividend Yield: 3.51%
• ROCE: 18.68%
• ROE: 14.80%
• Mojo Score: 47.0 (Sell)
• Market Cap Grade: Micro-cap

Price and Return Highlights

• Current Price: ₹93.95
• Day Change: +5.00%
• 52-Week Range: ₹52.25 – ₹125.00
• YTD Return: +36.77% vs Sensex -10.25%
• 3-Year Return: +92.52% vs Sensex +23.62%
• 5-Year Return: +115.48% vs Sensex +51.05%
• 10-Year Return: +403.75% vs Sensex +195.54%

Investors should continue to monitor Kriti Nutrients’ valuation relative to sector peers and broader market trends, especially given the recent downgrade in its valuation grade and Mojo rating.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →